Skip to main content
. Author manuscript; available in PMC: 2012 Dec 4.
Published in final edited form as: Expert Opin Emerg Drugs. 2012 Sep 21;17(4):439–444. doi: 10.1517/14728214.2012.720252

Table 3.

Methylene blue synergized isopentaquine efficacy against relapse by Chesson strain P. vivax in American prisoner volunteers.

Methylene blue* Isopentaquine‡ Quinine§ Relapsed/Challenged (%) Followup Duration
0 60 0 9/10 (90%) < 195 d
0 60 2,000 4/10 (40%) 167 – 374 d
500 60 0 3/9 (33%) 123 – 289 d
500 60 2,000 0/3 (0%) 249 d

Adapted from unpublished data of Alving et al. [29]

*

Milligrams of base & chloride salt of methylene blue, daily dose for 14 days.

Milligrams of base daily for 14 days

§

Millgrams of the sulfate salt of quinine